VanEck Associates’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54,364
| Closed | -$2.56M | – | 1394 |
|
|
2024
Q4 | $2.56M | Sell |
54,364
-17,327
| -24% | -$815K | ﹤0.01% | 909 |
|
|
2024
Q3 | $3.8M | Buy |
71,691
+12,565
| +21% | +$666K | ﹤0.01% | 744 |
|
|
2024
Q2 | $3.2M | Buy |
59,126
+1,233
| +2% | +$66.8K | ﹤0.01% | 737 |
|
|
2024
Q1 | $4.06M | Buy |
+57,893
| New | +$4.06M | 0.01% | 661 |
|